ProShares Ultra Nasdaq Biotechnology (BIB) Chart & Stock Price History $50.72 +0.64 (+1.28%) As of 01:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Stock Price Performance The ProShares Ultra Nasdaq Biotechnology (BIB) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 17.86%, with a year-to-date return of 0.12%. In the past month, the fund has increased 6.28%, reflecting recent market activity. As of the latest close, ProShares Ultra Nasdaq Biotechnology traded at $50.08 with a market cap of $50.58 million and volume of 12,115 shares. Five years ago, the fund traded at $71.52, representing a 29.08% decrease over that period. At the time, it had a market cap of $230.67 million and a volume of 104,028 shares. Receive BIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.57%1 Month Performance+6.28%3 Month Performance+22.98%Year-To-Date Performance+0.12%1 Year Performance-17.86%5 Year Performance-29.08% BIB Stock Chart for Friday, August, 8, 2025 BIB Chart by TradingView ProShares Ultra Nasdaq Biotechnology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$50.23$50.08-0.30%$50.09$49.2412,115 shs$50.58 million08/06/2025$51.52$50.23-2.50%$50.23$49.684,911 shs$50.73 million08/05/2025$53.06$51.52-2.90%$52.65$51.338,369 shs$52.04 million08/04/2025$51.01$53.06+4.02%$53.06$51.025,375 shs$53.59 million08/01/2025$50.48$51.01+1.05%$51.01$49.798,001 shs$51.52 million07/31/2025$51.14$50.48-1.28%$52.31$50.379,808 shs$50.99 million07/30/2025$51.22$51.14-0.17%$52.42$50.922,307 shs$51.65 million07/29/2025$51.34$51.22-0.23%$51.36$51.043,115 shs$51.73 million07/28/2025$52.55$51.34-2.30%$52.59$51.333,824 shs$51.85 million07/25/2025$52.62$52.55-0.13%$53.25$52.0911,879 shs$53.08 million Get the Latest News and Ratings for BIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$53.03$52.62-0.77%$53.25$52.464,330 shs$53.15 million07/23/2025$51.15$53.03+3.68%$53.15$51.6011,874 shs$53.56 million07/22/2025$48.90$51.15+4.60%$51.15$49.506,111 shs$51.66 million07/21/2025$49.15$48.90-0.51%$49.92$48.838,604 shs$49.39 million07/18/2025$50.64$49.15-2.94%$50.66$49.105,053 shs$49.64 million07/17/2025$50.42$50.64+0.44%$50.95$49.847,429 shs$51.15 million07/16/2025$48.60$50.42+3.74%$50.42$50.062,206 shs$50.92 million07/15/2025$50.77$48.60-4.27%$50.42$48.506,421 shs$49.09 million07/14/2025$49.63$50.77+2.29%$50.89$50.256,482 shs$51.28 million07/11/2025$51.33$49.63-3.30%$50.90$49.426,909 shs$50.13 million07/10/2025$50.23$51.33+2.19%$51.51$49.9814,573 shs$51.84 million07/09/2025$47.72$50.23+5.26%$50.29$48.9814,796 shs$50.73 million07/08/2025$46.92$47.72+1.71%$48.48$47.306,889 shs$48.67 million07/07/2025$48.34$46.92-2.94%$47.93$46.383,161 shs$47.86 million Related Companies F/m Emerald Life Sciences Innovation ETF Stock Price Chart Global X HealthTech ETF Stock Price Chart Invesco Nasdaq Biotechnology ETF Stock Price Chart Horizon Kinetics Medical ETF Stock Price Chart First Trust Nasdaq Pharmaceuticals ETF Stock Price Chart Invesco Dorsey Wright Healthcare Momentum ETF Stock Price Chart T. Rowe Price Health Care ETF Stock Price Chart JPMorgan Healthcare Leaders ETF Stock Price Chart ProShares UltraShort Nasdaq Biotechnology Stock Price Chart Invesco S&P SmallCap Health Care ETF Stock Price Chart Receive BIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares Ultra Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIB) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts